419 related articles for article (PubMed ID: 9528852)
1. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
[TBL] [Abstract][Full Text] [Related]
2. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
3. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.
Brzovic PS; Keeffe JR; Nishikawa H; Miyamoto K; Fox D; Fukuda M; Ohta T; Klevit R
Proc Natl Acad Sci U S A; 2003 May; 100(10):5646-51. PubMed ID: 12732733
[TBL] [Abstract][Full Text] [Related]
4. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1.
Meza JE; Brzovic PS; King MC; Klevit RE
J Biol Chem; 1999 Feb; 274(9):5659-65. PubMed ID: 10026184
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Ventii KH; Devi NS; Friedrich KL; Chernova TA; Tighiouart M; Van Meir EG; Wilkinson KD
Cancer Res; 2008 Sep; 68(17):6953-62. PubMed ID: 18757409
[TBL] [Abstract][Full Text] [Related]
6. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL; Vandenberg CJ; Hiom K
EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
[TBL] [Abstract][Full Text] [Related]
7. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
8. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
9. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
[TBL] [Abstract][Full Text] [Related]
10. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
11. BAP1, a candidate tumor suppressor protein that interacts with BRCA1.
Jensen DE; Rauscher FJ
Ann N Y Acad Sci; 1999; 886():191-4. PubMed ID: 10667217
[No Abstract] [Full Text] [Related]
12. Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1.
Jensen DE; Rauscher FJ
Cancer Lett; 1999 Sep; 143 Suppl 1():S13-7. PubMed ID: 10546591
[No Abstract] [Full Text] [Related]
13. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
Ayi TC; Tsan JT; Hwang LY; Bowcock AM; Baer R
Oncogene; 1998 Oct; 17(16):2143-8. PubMed ID: 9798686
[TBL] [Abstract][Full Text] [Related]
14. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
Baer R; Ludwig T
Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
[TBL] [Abstract][Full Text] [Related]
15. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzovic PS; Rajagopal P; Hoyt DW; King MC; Klevit RE
Nat Struct Biol; 2001 Oct; 8(10):833-7. PubMed ID: 11573085
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
17. The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins.
Irminger-Finger I; Siegel BD; Leung WC
Biol Chem; 1999 Feb; 380(2):117-28. PubMed ID: 10195418
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
Xia Y; Pao GM; Chen HW; Verma IM; Hunter T
J Biol Chem; 2003 Feb; 278(7):5255-63. PubMed ID: 12431996
[TBL] [Abstract][Full Text] [Related]
19. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
20. A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.
Parrotta R; Okonska A; Ronner M; Weder W; Stahel R; Penengo L; Felley-Bosco E
J Thorac Oncol; 2017 Aug; 12(8):1309-1319. PubMed ID: 28389374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
